v3.26.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Preferred Stock Dividend Declaration and Payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2025 through March 31, 2026:

Declaration Date Record DatePayment Date
Annual Dividend Rate
Dividend Per Share
February 19, 2026March 4, 2026March 31, 20267.50%$0.46875
November 20, 2025December 4, 2025December 31, 20257.500.46875
August 21, 2025September 4, 2025September 30, 20257.500.46875
May 19, 2025June 4, 2025June 30, 20257.500.46875
February 18, 2025March 4, 2025March 31, 20257.500.46875
Schedule of Cash Dividends on its Preferred Stock and Common Stock
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2025 through March 31, 2026:

Declaration Date Record DatePayment Date
Annual Dividend Rate
Dividend Per Share
February 19, 2026March 4, 2026March 31, 20269.27855%$0.579910
November 20, 2025December 4, 2025December 31, 20259.608110.613850
September 2, 2025September 4, 2025September 30, 20259.902260.639521
May 19, 2025June 4, 2025June 30, 20259.905780.619110
February 18, 2025March 4, 2025March 31, 20256.500000.406250
The following table presents cash dividends declared by the Company on its common stock from January 1, 2025 through March 31, 2026:

Declaration Date
Record DatePayment DateDividend Per Share 
March 5, 2026March 31, 2026April 30, 2026$0.36(1)
December 11, 2025December 31, 2025January 30, 20260.36
September 11, 2025September 30, 2025October 31, 20250.36
June 12, 2025June 30, 2025July 31, 20250.36
March 6, 2025March 31, 2025April 30, 20250.36
(1) At March 31, 2026, the Company had accrued dividends and dividend equivalents payable of $37.7 million related to the common stock dividend declared on March 5, 2026.
Schedule of Changes in Balances of each Component of the Entity's AOCI
The following tables present changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2026 and 2025:
Three Months Ended March 31, 2026
(In Thousands)Net Unrealized Gain/(Loss) on AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total AOCI
Balance at beginning of period$3,675 $— $3,675 
OCI before reclassifications(753)— (753)
Amounts reclassified from AOCI— — — 
Net OCI during the period (2)
(753)— (753)
Balance at end of period$2,922 $— $2,922 
Three Months Ended March 31, 2025
(In Thousands)Net Unrealized Gain/(Loss) on AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total AOCI
Balance at beginning of period$9,476 $— $9,476 
OCI before reclassifications(1,034)— (1,034)
Amounts reclassified from AOCI(226)— (226)
Net OCI during the period (2)
(1,260)— (1,260)
Balance at end of period$8,216 $— $8,216 
(1) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).